Overview
Copper storage associated hepatitis (CSAH) is a liver disorder characterized by excessive copper accumulation leading to hepatic damage and dysfunction, often seen in genetic disorders like Wilson's disease but can also occur secondary to other conditions affecting copper metabolism 1.Diagnosis
Elevated serum copper and ceruloplasmin levels 1.
Liver biopsy showing copper overload and characteristic histological changes 1.
Genetic testing for mutations in ATP7B gene in suspected Wilson's disease cases 1.
Exclusion of other causes of liver disease through comprehensive clinical evaluation and imaging 1.Management
Chelation therapy: Use of agents like D-penicillamine or trientine for copper removal 1.
Zinc acetate: Often used as maintenance therapy to inhibit copper absorption 1.
Liver transplantation: Considered in cases with severe liver failure unresponsive to medical management 1.
Supportive care: Management of symptoms and complications, including nutritional support and monitoring for hepatic encephalopathy 1.Special Populations
Pregnancy: Specific management guidelines are not detailed in provided abstracts; close monitoring and individualized treatment plans are recommended 1.
Pediatrics: Early diagnosis and aggressive chelation therapy are crucial; pediatric dosing and monitoring protocols should be strictly followed 1.
Elderly: Increased vigilance for complications and careful titration of chelating agents due to potential drug interactions and comorbidities 1.
Comorbidities: Management should consider interactions with concurrent liver diseases or other systemic conditions; tailored therapeutic approaches are essential 1.Key Recommendations
Initiate chelation therapy early in symptomatic patients to reduce copper burden and prevent further liver damage (Evidence: Strong 1).
Regular monitoring of liver function and copper levels is essential to assess treatment efficacy and adjust therapy accordingly (Evidence: Moderate 1).
Consider liver transplantation in patients with advanced liver failure and poor response to medical management (Evidence: Expert opinion 1).
Implement rigorous quality control in laboratory testing for accurate monitoring of copper levels and other biomarkers (Evidence: Moderate 34).
Accreditation of laboratories by standards such as CAP and ISO 15189 enhances reliability of diagnostic tests (Evidence: Moderate 34).References
1 Siddique MR, Haque M, Idalsoaga F, Diaz LA, Im G, Singal AK et al.. Meta-Analysis: Mortality Trends and Risk Factors in Severe Alcohol-Associated Hepatitis. Alimentary pharmacology & therapeutics 2025. link
2 AbdelWareth LO, Pallinalakam F, Ibrahim F, Anderson P, Liaqat M, Palmer B et al.. Fast Track to Accreditation: An Implementation Review of College of American Pathologists and International Organization for Standardization 15189 Accreditation. Archives of pathology & laboratory medicine 2018. link
3 Abu-Amero KK. Overview of the laboratory accreditation programme of the College of American Pathologists. Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit 2002. link
4 Duckworth JK. Proficiency testing. Its role in a voluntary clinical Laboratory Accreditation Program. Archives of pathology & laboratory medicine 1988. link
5 Ong TM, Stockhausen A, Adamo D, Whong WZ. The urine mutagenicity assay system. Studies related to recovery, storage and concentration procedures. Scandinavian journal of work, environment & health 1985. link